Three trends in the antibody-drug conjugate (ADC) market
Drug Discovery World
JUNE 1, 2023
A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2. Under the terms of the licensing agreement, AstraZeneca will be granted an exclusive global license to research, develop, and commercialize LM-305.
Let's personalize your content